Invention Publication
![FUSED [7,5] BICYCLIC PYRAZOLE DERIVATIVES AND METHODS OF USE THEREOF FOR THE TREATMENT OF HERPESVIRUSES](/docs/US/2024-02-15/US20240051963A1/abs.jpg.600x600.jpg)
- Patent Title: FUSED [7,5] BICYCLIC PYRAZOLE DERIVATIVES AND METHODS OF USE THEREOF FOR THE TREATMENT OF HERPESVIRUSES
-
Application No.: US18256980Application Date: 2021-12-09
-
Publication No.: US20240051963A1Publication Date: 2024-02-15
- Inventor: Andrew J. Cooke, JR. , Jeffrey W. Schubert , Jason W. Skudlarek
- Applicant: Andrew J. Cooke, JR. , Jeffrey W. Schubert , Jason W. Skudlarek , Merck Sharp & Dohme LLC.
- Applicant Address: US PA Doylestown
- Assignee: Merck Sharp & Dohme LLC
- Current Assignee: Merck Sharp & Dohme LLC
- Current Assignee Address: US NJ Rahway
- International Application: PCT/US2021/062507 2021.12.09
- Date entered country: 2023-06-12
- Main IPC: C07D487/04
- IPC: C07D487/04 ; A61K31/517 ; A61P31/22
![FUSED [7,5] BICYCLIC PYRAZOLE DERIVATIVES AND METHODS OF USE THEREOF FOR THE TREATMENT OF HERPESVIRUSES](/abs-image/US/2024/02/15/US20240051963A1/abs.jpg.150x150.jpg)
Abstract:
The present invention relates to novel Fused [7,5] Bicyclic Pyrazole Derivatives of Formula (I): (I) and pharmaceutically acceptable salts thereof, wherein X, R1, R2, R3, and R4 are as defined herein. The present invention also relates to compositions comprising at least one Fused [7,5] Bicyclic Pyrazole Derivative, and methods of using the Fused [7,5] Bicyclic Pyrazole Derivatives for treating or preventing a herpesvirus infection in a patient.
Information query
